The University of Colorado at Boulder has received a $15 million grant through the American Recovery and Reinvestment Act to be used toward the ongoing construction of a revolutionary biotechnology and biomedical research facility where faculty and students will tackle a variety of human health challenges.
Construction of the new facility, which when completed is expected to host more than 60 faculty members and more than 500 graduate students, researchers and support staff, began in September 2009. Faculty and students will use the facility for fundamental research that is expected to make an impact on a wide variety of human health issues ranging from cancer, aging and cardiovascular disease to inherited diseases, vaccine development and regenerative medicine.
The ARRA money was awarded to ¶¶ÒõÂÃÐÐÉä-Boulder's Colorado Initiative in Molecular Biotechnology, or CIMB, through the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. ¶¶ÒõÂÃÐÐÉä-Boulder Distinguished Professor and CIMB Director Tom Cech said the new facility will serve as a springboard to further research, teaching and technology at the intersection of the life sciences with the physical sciences, math, computational sciences and engineering.
The new biotechnology facility will bolster Colorado's position in the nation's biotechnology economy, said Cech. The first phase of the building comprising 266,400 square feet is slated for completion in fall 2011, with plans for a 70,400-square-foot addition at a later date. It also will house CIMB faculty from the department of chemical and biological engineering, and biochemistry division faculty from the department of chemistry and biochemistry.
"This is such an appropriate use of ARRA funds, because the Biotechnology Building will create jobs at three stages – construction jobs in the near term, laboratory research positions once the building is occupied, and biotechnology jobs in Colorado over the following years as we work to enhance that industry in the state," said Cech.
Cech said prior to the ARRA award, much of the interior space of the facility now under construction had been destined to remain as shell space pending more funding. "We thank the NIH for approving our request for $15 million, which will build out space for the biochemistry faculty of ¶¶ÒõÂÃÐÐÉä-Boulder," said Cech, who shared the 1989 Nobel Prize in chemistry and served as the Howard Hughes Medical Institute president from 2000 to 2009 while retaining his ¶¶ÒõÂÃÐÐÉä faculty appointment.
NIH's National Center for Research Resources, or NCRR, received nearly 1,200 applications for such construction projects totaling more than $10.6 billion. NCRR received $1 billion in ARRA funds for the program, so the success rate for the winners was less than 10 percent.
Before the ARRA grant to ¶¶ÒõÂÃÐÐÉä-Boulder, more than half of the building's $145 million Phase One cost had already been committed, including more than $60 million from the university and more than $30 million in gifts from generous donors. Fundraising efforts for the new facility are ongoing to cover the remaining costs of the full building plan.
The new facility is named the Jennie Smoly Caruthers Biotechnology Building after an adjunct professor in ¶¶ÒõÂÃÐÐÉä-Boulder's chemistry and biochemistry department and the late wife of ¶¶ÒõÂÃÐÐÉä-Boulder Distinguished Professor Marvin Caruthers. The facility will offer the opportunity for a wide swath of researchers to collaborate, said Professor Leslie Leinwand, Marsico Professor of Excellence and Chief Scientific Officer of CIMB.
In addition to interdisciplinary collaboration involving faculty and students, the modern equipment in the facility will give biotech companies the chance to come in and work with ¶¶ÒõÂÃÐÐÉä-Boulder faculty and students, said Leinwand. It also will help ¶¶ÒõÂÃÐÐÉä build on its distinguished record in biotechnology research, which has generated more than a dozen biotech startup companies and currently attracts tens of millions of dollars annually in sponsored research awards.
Colorado boasts particular strength in the biosciences, with its businesses generating more than $400 million in state taxes and supporting 36,000 workers. Coupled with ¶¶ÒõÂÃÐÐÉä's strong startup track record and accomplished faculty researchers, the new building should further bolster the region's biotech strength, said Cech.
Other activities within the new building will involve ¶¶ÒõÂÃÐÐÉä-Boulder undergraduates. The university offers funding to hundreds of undergraduates annually for biomedical research, said Cech.
More information on the Biotechnology Building and the Colorado Initiative in Molecular Biotechnology is available at /.
FACT SHEET
Jennie Smoly Caruthers Biotechnology Building
* The Jennie Smoly Caruthers Biotechnology Building is a $145 million research and teaching facility being built on the East Campus of the University of Colorado at Boulder. Construction began in September 2009.
* The facility is expected to enhance science and engineering education and discovery at ¶¶ÒõÂÃÐÐÉä-Boulder and bolster Colorado's role in the national biotechnology economy. The first phase of the building comprising 266,400 square feet is slated for completion in November 2011. There are plans for a 70,400-square-foot addition at a later date. Fundraising for the new facility is ongoing.
* ¶¶ÒõÂÃÐÐÉä-Boulder's Colorado Initiative in Molecular Biotechnology, or CIMB, received a $15 million grant toward ongoing construction of the building in 2010 through the National Institutes of Health, an agency of the U.S. Department of Health and Human Services, as part of the American Recovery and Reinvestment Act.
* Jobs for the project are being created at the construction level, as well as new faculty, support staff and administrative staff that are being hired. The new facility also is expected to stimulate new jobs in Colorado's biotechnology industry.
* CIMB is directed by ¶¶ÒõÂÃÐÐÉä-Boulder Distinguished Professor and Nobel laureate Tom Cech. ¶¶ÒõÂÃÐÐÉä-Boulder Professor Leslie Leinwand, Marsico Professor of Excellence, is the chief scientific officer of CIMB.
* Faculty, staff and students in the facility will do basic research to better understand cancer, aging, cardiovascular disease and inherited diseases, and will engage in vaccine development and tissue engineering. ¶¶ÒõÂÃÐÐÉä-Boulder will be collaborating more closely with faculty and students at the University of Colorado Denver Anschutz Medical Campus.
* The building will provide LEED-certified laboratory space. LEED standards are issued by the United States Green Building Council, and LEED certification is a U.S. benchmark for "green" building design, construction, operation and maintenance.
* Activities in the new Biotechnology Building will involve local and national experts in the business and scientific aspects of biotechnology as well as the entrepreneurship program at ¶¶ÒõÂÃÐÐÉä's Leeds School of Business. Colorado's bioscience industry generates more than $400 million in state taxes annually and supports 36,000 employees.
* The building was named after Jennie Smoly Caruthers, the late wife of ¶¶ÒõÂÃÐÐÉä-Boulder Distinguished Professor Marvin Caruthers of the chemistry and biochemistry department. Jennie Smoly Caruthers is a former ¶¶ÒõÂÃÐÐÉä-Boulder adjunct professor.
* The design and construction of the new facility involves HDR Architects Inc. in association with Robert A.M. Stern Architects, as well as general contractor JE Dunn Construction.
For more information contact Cech at 303-492-5069, Leinwand at 303-492-7606 or Jim Scott in the Office of Media Relations and News Services at 303-492-3114. For more information on CIMB visit .
